Font Size:
a
A
A
Keyword [HER2-positive]
Result: 101 - 111 | Page: 6 of 6
101.
Prognostic Analysis Of 311 Patients With Early HER2-Positive Breast Cancer
102.
Prognostic Implications Of The Pathological Prognostic Staging System Of The AJCC 8th Edition For Patients With HER2-positive Breast Cancer
103.
Efficacy And Safety Of Dual HER2 Blockade Versus A Single-Agent In Trastuzumab-Containing Regimens For HER2-Positive Early Breast Cancer:A Meta-analysis
104.
Meta-analysis Of The Efficacy And Safety Of Neoadjuvant Trastuzumab Combined With Pertuzumab For HER2-positive Breast Cancer
105.
Observational Study Of Adjuvant And Neoadjuvant Dual-target Therapy For HER2 Positive Breast Cancer
106.
Predictive Value Of HER2 Protein Expression Level In Pat Ients With HER2-positive Breast Cancer Receiving Neoadj Uvant Therapy
107.
Comparisons Of Efficacy And Safety Of Different Second-line Treatments For Trastuzumab-resistant Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
108.
M6A Demethylase FTO Promotes The Resistance Of HER2-positive Breast Cancer Cell To Trastuzumab
109.
Study On The Expression Of Related Molecules In The Process Of Drug Resistance And Reversal Of Trastuzumab In HER2 Positive Breast Cancer Cells
110.
Research On The Mechanism Of Taxol Resistance Of The HER2-positive Breast Cancer Cell Line SKBR-3
111.
The Synergistic Effect Of Nrf2 Inhibitor In Combination With Trastuzumab In HER2-positive Tumors And Its Mechanism Of Action
<<First
<Prev
Next>
Last>>
Jump to
